SciELO - Scientific Electronic Library Online

 
vol.19 issue1-2Addison disease and pregnancyTrombocytopenia and Sarcoidosis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Arquivos de Medicina

On-line version ISSN 2183-2447

Arq Med vol.19 no.1-2 Porto Jan. 2005

 

Epilepsia e Gravidez: Que Conduta?

A Propósito de Um Caso Clínico

 

Carla Tovim Rodrigues*; Miguel Branco†, Isabel Ferreira*; Paula Estanqueiro†; Teresa Vicente*; Isabel Silva*; Ana Couceiro*; Conceição Ramos‡

 

Serviços de *Obstetrícia/Ginecologia e ‡Neonatologia da Maternidade Bissaya-Barreto; †Serviço de Pediatria do Hospital Pediátrico de Coimbra.

 

A epilepsia representa a patologia neurológica mais comum durante a gravidez. Na maioria dos casos decorre sem intercorrências mas o risco obstétrico e de complicações neonatais está aumentado. Os antiepilépticos estão associados a um risco duas a três vezes maior de malformações major. Os autores apresentam o caso clínico de uma grávida com epilepsia desde os 20 anos de idade e de difícil controlo. A primeira gravidez, na qual esteve medicada com valproato de sódio, terminou às 23 semanas de gestação por diagnóstico de espinha bífida. Posteriormente foi medicada em pré-concepcional com carbamazepina e suplementos de ácido fólico. Engravidou após um bom controlo da doença, tendo esta gravidez decorrido sem complicações.

Palavras-chave: gravidez, epilepsia, vigilância pré-natal, anti-epilépticos, defeitos do tubo neural, profilaxia com ácido fólico.

 

Epilepsy and Pregnancy: What Management?

Epilepsy is the most common neurological disturbance during pregnancy. The vast majority of these pregnancies are uncomplicated, but there are increased obstetric risks and increased adverse neonatal outcomes compared with the general population. Antiepileptic treatment during pregnancy is associated with two to three-fold increase in the rate of major congenital anomalies. The authors present a case report of a pregnant woman with epilepsy since 20 years old, with difficult control of seizures. The first pregnancy, in witch she was treated with valproate, was terminated at 23 weeks’ gestation because the fetus developed a spina bifida. In a pre conceptional consultancy she was treated with carbamazepina and acid folic supplementation. She get pregnant after a good control of the disease, and had a healthy child.

Key-words: pregnancy, epilepsy, prenatal screening,

 

Texto completo disponível apenas em PDF.

Full text only available in PDF format.

 

REFERÊNCIAS

1 - Kilpatrick CJ, Hopper JL. O efeito exercido pela gravidez sobre a epilepsia, segundo um estudo de 37 gravidezes. Revista de Obstetrícia e Ginecologia 1994;17:373-5.         [ Links ]

2 - Page B, Pennell MD. Pregnancy in woman with epilepsy: maternal and fetal outcomes. Seminars in Neurology 2002; 22:299-307.

3 - Waters CH, Belai Y, Gottps, et al. Outcomes of pregnancy associated with antiepileptic drugs. Arch Neurol 1994;51:250-3.

4 - Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsivant drugs. N Engl J M 2001;344:1132-8.

5 - Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Archives of Disease in Childhood 1996;75:517-20.

6 - Jones KL, Lacro RV, Johnson KA, Adams JA. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1991;321:674-7.

7 - Beghi E, Annegers J. for the Collaborative Group for the Pregnancy Registries in Epilepsy. Epilepsia 2001;42:1422-25.

8 - Oguni M, Osawa M. Epilepsy and pregnancy. Epilepsia 2004;45:37-41.

9 - Kaplan PW. Reproductive health effects and teratogenicity of antiepileptic drugs. Neurology 2004;63:13-23.

10 - Tomson T, Peruca E, Battino D. Navigating toward fetal and maternal health: the challenge of trating epilepsy in pregnancy. Epilepsia 2004;45:1171-5.

11 - Sabers A, Dam M, A-Rogvi-Hansen B, et al. Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand 2004;109:9-13.

12 - Cunnington MC. The international lamotrigine pregnancy registry update for the epilepsy foundation. Epilepsia 2004;45:1468.

13 - Pennell PB. The importance of monotherapy in pregnancy. Neurology 2003;60(11 suppl 4):S31-8.

14 - Report of the Quality Standarts Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Neurology 1998;51:944-8.

15 - Pschirrer E, Monga M. Seizure disorders in pregnancy. Obstet Gynecol Clin 2001;28:601-11.

16 - Richard A, Bronsteen MD, Christine H, et al. Central Nervous System Anomalies. Clin in Perinatol 2000; 27: 791812.

17 - Malone F, Dalton M. Drugs in pregnancy: anticonvulsivants. Semin Perinatol 1997; 21:114-23.

18 - Lynn L, Simpson MD. Structural Cardiac Anomalies. . Clin in Perinatol 2000; 27: 839-63.

19 - Adab N, Tudur SC, Vinten J, Willianson P, Winterbotton J. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Rev 2004;CD004848.

 

Correspondência:

Dr.ª Carla Tovim Rodrigues

Serviço de Obstetrícia

Maternidade Bissaya-Barreto

Rua Augusta 3000 Coimbra

e-mail: carlatr1@hotmail.com

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License